Zomedica (ZOM) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Zomedica (NYSEAMERICAN:ZOM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.19%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$37KNumber OfInsiders Selling(Last 12 Months)0 Get ZOM Insider Trade Alerts Want to know when executives and insiders are buying or selling Zomedica stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ZOM Insider Buying and Selling by Quarter Zomedica Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/11/2024Johnny D PowersDirectorBuy100,000$0.12$12,000.00 9/5/2024Larry C Heaton IICEOBuy100,000$0.12$12,000.00 8/28/2024Johnny D PowersDirectorBuy100,000$0.13$13,000.00 (Data available from 1/1/2013 forward) ZOM Insider Trading Activity - Frequently Asked Questions Who is on Zomedica's Insider Roster? The list of insiders at Zomedica includes Anthony K Blair, Johnny D Powers, Larry C Heaton II, Peter Donato, and Russell Kevin Klass. Learn more on insiders at ZOM. What percentage of Zomedica stock is owned by insiders? 4.19% of Zomedica stock is owned by insiders. Learn more on ZOM's insider holdings. Which Zomedica insiders have been buying company stock? The following insiders have purchased ZOM shares in the last 24 months: Anthony K Blair ($21,000.00), Johnny D Powers ($87,500.00), Larry C Heaton II ($26,000.00), Peter Donato ($3,750.00), and Russell Kevin Klass ($47,998.88). How much insider buying is happening at Zomedica? Insiders have purchased a total of 1,249,993 ZOM shares in the last 24 months for a total of $186,248.88 bought. Zomedica Key ExecutivesMr. Larry C. Heaton II (Age 67)President, CEO & Director Compensation: $651.4kMr. Peter L. Donato BSBA (Age 54)M.B.A., Chief Financial Officer Compensation: $311.01kMr. Russell Kevin Klass (Age 57)Senior Vice President of Sales Compensation: $215.23kMr. Anthony K. Blair (Age 63)Chief Operating Officer Mr. Evan St. Peter M.B.A.Vice President of Technology InnovationMs. Karen L. DeHaan-Fullerton J.D. (Age 55)Chief Counsel & Corporate Secretary Ms. Nicole Westfall M.B.A.Senior Vice President of MarketingMs. Kristin DomanskiVice President of Human ResourcesMr. Greg BlairSenior Vice President of Business Development & Strategic PlanningMr. Robert W. DiMarzo (Age 67)Consultant Compensation: $291.2k More Insider Trading Tools from MarketBeat Related Companies RVNC Insider Trades VIGL Insider Trades SVRA Insider Trades TERN Insider Trades ARCT Insider Trades FULC Insider Trades CKPT Insider Trades AQST Insider Trades HUMA Insider Trades AMRN Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Do They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield WatchlistInsider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold? This page (NYSEAMERICAN:ZOM) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zomedica Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
